OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit

PR Newswire · 10/17 18:58

NEW YORK, Oct. 17, 2024 /PRNewswire/ -- 

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the "Class Period"), of the important October 21, 2024 lead plaintiff deadline.

So what: If you purchased Orthofix common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Orthofix class action, go to https://rosenlegal.com/submit-form/?case_id=19330 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made misleading statements and omissions regarding Orthofix's business, financial condition, and prospects. Specifically, defendants failed to disclose that certain of Orthofix's management team had engaged in repeated inappropriate and offensive conduct. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Orthofix class action, go to https://rosenlegal.com/submit-form/?case_id=19330 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

case@rosenlegal.com

www.rosenlegal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ofix-investors-have-opportunity-to-lead-orthofix-medical-inc-securities-fraud-lawsuit-302279559.html

SOURCE THE ROSEN LAW FIRM, P. A.